February 7, 2014
For More Information
As this article has made clear, the HCV treatment landscape is rapidly shifting, and today's realities are quickly giving way to tomorrow's developments. Keep yourself informed by checking in with quality resources for health care providers.
Myles Helfand is the editorial director of TheBody.com and TheBodyPRO.com.
Follow Myles on Twitter: @MylesatTheBody.
|This Week in HIV Research: HIV Reservoirs Remain Obstacles to Cure; "Redesigned" Antibodies Show Promise; and Is 85% Adherence Enough?|
|HIV-Positive Individuals on Treatment Lose More Years of Life to Smoking Than to HIV|
|More Age-Related Illnesses in Older People With HIV Than Comparable HIV-Negatives|
|Advocates for Women Talk About CROI 2015|
|Novel, Broadly Active HIV Inhibitor Shows Potential for Vaccine|
|Statin Therapy for 1 Year Linked to Gains in Bone Density With HIV|